Yasuoka H - Search Results

1

Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjögren's syndrome.

Tasaki S, Suzuki K, Nishikawa A, Kassai Y, Takiguchi M, Kurisu R, Okuzono Y, Miyazaki T, Takeshita M, Yoshimoto K, Yasuoka H, Yamaoka K, Ikeura K, Tsunoda K, Morita R, Yoshimura A, Toyoshiba H, Takeuchi T. Tasaki S, et al. Among authors: yasuoka h. Ann Rheum Dis. 2017 Aug;76(8):1458-1466. doi: 10.1136/annrheumdis-2016-210788. Epub 2017 May 18. Ann Rheum Dis. 2017. PMID: 28522454 Free PMC article.

2

Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndrome.

Nishikawa A, Suzuki K, Kassai Y, Gotou Y, Takiguchi M, Miyazaki T, Yoshimoto K, Yasuoka H, Yamaoka K, Morita R, Yoshimura A, Takeuchi T. Nishikawa A, et al. Among authors: yasuoka h. Arthritis Res Ther. 2016 May 14;18(1):106. doi: 10.1186/s13075-016-1006-1. Arthritis Res Ther. 2016. PMID: 27180164 Free PMC article.

3

CC-chemokine ligand 18 is a useful biomarker associated with disease activity in IgG4-related disease.

Akiyama M, Yasuoka H, Yoshimoto K, Takeuchi T. Akiyama M, et al. Among authors: yasuoka h. Ann Rheum Dis. 2018 Sep;77(9):1386-1387. doi: 10.1136/annrheumdis-2017-212110. Epub 2017 Oct 13. Ann Rheum Dis. 2018. PMID: 29030359 Free PMC article. No abstract available.

4

Number of Circulating Follicular Helper 2 T Cells Correlates With IgG4 and Interleukin-4 Levels and Plasmablast Numbers in IgG4-Related Disease.

Akiyama M, Suzuki K, Yamaoka K, Yasuoka H, Takeshita M, Kaneko Y, Kondo H, Kassai Y, Miyazaki T, Morita R, Yoshimura A, Takeuchi T. Akiyama M, et al. Among authors: yasuoka h. Arthritis Rheumatol. 2015 Sep;67(9):2476-81. doi: 10.1002/art.39209. Arthritis Rheumatol. 2015. PMID: 25989153

5

Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease.

Akiyama M, Yasuoka H, Yamaoka K, Suzuki K, Kaneko Y, Kondo H, Kassai Y, Koga K, Miyazaki T, Morita R, Yoshimura A, Takeuchi T. Akiyama M, et al. Among authors: yasuoka h. Arthritis Res Ther. 2016 Jul 13;18:167. doi: 10.1186/s13075-016-1064-4. Arthritis Res Ther. 2016. PMID: 27411315 Free PMC article.

6

Increased proportion of a CD38^highIgD⁺ B cell subset in peripheral blood is associated with clinical and immunological features in patients with primary Sjögren's syndrome.

Ishioka-Takei E, Yoshimoto K, Suzuki K, Nishikawa A, Yasuoka H, Yamaoka K, Takeuchi T. Ishioka-Takei E, et al. Among authors: yasuoka h. Clin Immunol. 2018 Feb;187:85-91. doi: 10.1016/j.clim.2017.10.008. Epub 2017 Oct 20. Clin Immunol. 2018. PMID: 29061446

7

Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.

Akiyama M, Sasaki T, Kaneko Y, Yasuoka H, Suzuki K, Yamaoka K, Takeuchi T. Akiyama M, et al. Among authors: yasuoka h. Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):157-164. Epub 2018 Feb 15. Clin Exp Rheumatol. 2018. PMID: 29465360 Free article.

8

Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission.

Tasaki S, Suzuki K, Kassai Y, Takeshita M, Murota A, Kondo Y, Ando T, Nakayama Y, Okuzono Y, Takiguchi M, Kurisu R, Miyazaki T, Yoshimoto K, Yasuoka H, Yamaoka K, Morita R, Yoshimura A, Toyoshiba H, Takeuchi T. Tasaki S, et al. Among authors: yasuoka h. Nat Commun. 2018 Jul 16;9(1):2755. doi: 10.1038/s41467-018-05044-4. Nat Commun. 2018. PMID: 30013029 Free PMC article.

9

Thymus variants on imaging in patients with rheumatoid arthritis-clinical and immunological significance.

Murata O, Suzuki K, Sugiura H, Kondo Y, Takeshita M, Koga K, Takiguchi M, Kurisu R, Kassai Y, Yasuoka H, Yamaoka K, Morita R, Yoshimura A, Takeuchi T. Murata O, et al. Among authors: yasuoka h. Rheumatology (Oxford). 2021 Dec 1;60(12):5595-5600. doi: 10.1093/rheumatology/keab164. Rheumatology (Oxford). 2021. PMID: 33590850

10

Peripheral TIGIT+ T Follicular Helper Cells That Produce High Levels of Interleukin-21 via OX40 Represent Disease Activity in IgG4-Related Disease.

Akiyama M, Suzuki K, Yoshimoto K, Yasuoka H, Kaneko Y, Takeuchi T. Akiyama M, et al. Among authors: yasuoka h. Front Immunol. 2021 Apr 14;12:651357. doi: 10.3389/fimmu.2021.651357. eCollection 2021. Front Immunol. 2021. PMID: 33936071 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters